A tailored version of the DASH eating plan, called DASH4D, has been shown to significantly improve blood sugar markers in adults with type 2 diabetes, especially among those with higher initial A1c levels, according to Johns Hopkins research.
A modified DASH eating plan designed for people with type 2 diabetes lowered key measures of blood sugar control in a Johns Hopkins analysis of a controlled feeding trial, according to research published in Diabetes Care. The diet, known as DASH4D, produced better results than a menu pattern intended to reflect typical US eating habits, with the strongest effects seen in participants whose starting A1c was at least 7%.
The study followed 101 adults with type 2 diabetes, with an average age of 67 and most participants being women. Researchers fed volunteers four different diets in random order over five-week periods, including the DASH4D plan and a comparison diet, each tested with higher and lower sodium levels. Meals were prepared in a metabolic kitchen, body weight was kept stable and adherence was high throughout the trial.
Compared with the comparison diet, DASH4D led to statistically significant reductions in fructosamine, fasting glucose and A1c. Fructosamine, which reflects average glucose over roughly two to four weeks, fell by 5.6 micromoles per litre, fasting glucose dropped by 4.5 mg/dL and A1c declined by 0.09 percentage points. In exploratory analyses, people with higher starting A1c levels appeared to benefit most, especially for fructosamine and fasting glucose.
The diet itself emphasises fruits, vegetables, whole grains and low-fat dairy, while trimming back the features more typical of an American diet, such as red meat and sugar-sweetened foods. Johns Hopkins researchers have previously said DASH4D was created as a simpler, more practical version of the original DASH approach for people with diabetes, balancing lower carbohydrate intake with more unsaturated fats. Earlier reporting on the same trial also found the diet improved time spent in the target glucose range, suggesting the benefits may extend beyond standard laboratory markers.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
